2019 HOPA Annual Conference
2019 HOPA Annual Conference
Advertisement
DocWire News Editors2019 HOPA Annual Conference | April 3, 2023
Prostate cancer screening with prostate-specific antigen (PSA) and digital rectal exams should be a shared decision ...
Read More
DocWire News Editors2019 HOPA Annual Conference | September 11, 2023
There exist unique challenges with respect to managing and treating the elderly with cancer, and functional age, ...
DocWire News Editors2019 HOPA Annual Conference | September 11, 2023
Moderate evidence suggests that using medical marijuana can benefit chemotherapy-induced nausea and vomiting (CINV), as ...
DocWire News Editors2019 HOPA Annual Conference | September 11, 2023
A recent review presented by Christy S. Harris, PharmD, BCOP, Associate Professor, Pharmacy Practice, MCPHS-Boston, at ...
Rob Dillard2019 HOPA Annual Conference | April 10, 2023
Given that pediatric oncologists experience first-hand chronic mortality of young patients, this subset of physicians ...
Rob Dillard2019 HOPA Annual Conference | April 24, 2019
Brentuximab Vedotin (BV) is effective and safe in patients with advanced staged Hodgkin’s Lymphoma according to the ...
Rob Dillard2019 HOPA Annual Conference | April 24, 2019
Sunitinib is effective in those categorized with favorable risk Renal Cell Carcinoma, according to a survey of the ...
Rob Dillard2019 HOPA Annual Conference | August 28, 2023
New advances in treatment options for Chronic Lymphocytic Leukemia (CLL) were examined in the presentation given by ...
Advertisement
Advertisement
Advertisement
Latest News

January 7, 2025